Workflow
NATIXIS ODDO BHF
icon
Search documents
ARGAN: HALF-YEAR ASSESSMENT LIQUIDITY CONTRACT WITH ODDO
Globenewswire· 2026-01-14 16:45
Core Insights - ARGAN is a leading French real estate company specializing in the development and rental of premium warehouses, with a focus on sustainability and customer-centric services [3][4] - As of December 31, 2025, ARGAN's portfolio includes 3.8 million square meters of warehouse space, valued at €4.1 billion, generating an annual rental income of €214 million [3] - The company maintains a strong financial position, reflected in its investment-grade rating of BBB- with a stable outlook from Standard & Poor's [4] Financial Performance - The liquidity contract with NATIXIS ODDO BHF shows significant trading volumes, with 230,160 shares purchased for €14,980,043 and 226,705 shares sold for €14,785,373.2 during the specified period [7] - The financial calendar for 2026 includes key dates for annual results and general assemblies, indicating a structured approach to financial reporting [7] Sustainability and ESG - ARGAN is committed to an ESG policy that addresses all stakeholders, achieving high ratings from third-party agencies such as GRESB (83/100), Sustainalytics (low extra-financial risk), Ethifinance (gold medal), and Ecovadis (silver medal) [4]
Rexel: biannual sharebuyback program at December 31, 2025
Globenewswire· 2026-01-08 17:00
BIANNUAL UPDATE OF THE LIQUIDITY AGREEMENT BETWEEN REXEL AND NATIXIS-ODDO BHF (2025/12/31) Under the terms of the liquidity and market monitoring agreement concluded with NATIXIS ODDO BHF and covering Rexel shares, on December 31, 2025 the following resources were included in the liquidity account: - 145,920 REXEL shares - € 18,308,308.04 It is reminded that at the date of implementation of the agreement, the liquidity account contained the following resources: - 626,370 REXEL shares - € 8,211,228.57 ...
Ipsen – Half year statement – 2025 12 31
Globenewswire· 2026-01-06 17:00
Core Viewpoint - Ipsen has provided a half-year statement regarding its liquidity agreement with NATIXIS ODDO BHF, detailing the resources allocated to the liquidity account as of December 31, 2025, and the trading volume executed during the second half of 2025 [1]. Group 1: Company Overview - Ipsen is a global biopharmaceutical company focused on transformative medicines in oncology, rare diseases, and neuroscience, with nearly 100 years of development experience [2]. - The company operates in over 40 countries and partners globally to deliver medicines to more than 100 countries [2]. Group 2: Financial Details - As of December 31, 2025, the liquidity account included resources amounting to €2,126,437.66 from 30,064 shares and €3,137,934.80 from 12,751 shares [6]. - The trading volume during the period from July 1, 2025, to December 31, 2025, included 384,725 shares purchased for €44,989,151.30 and 392,691 shares sold for €45,795,172 [6].
Half-year statement on Nexans liquidity contract - July 1st to December 31st, 2025
Globenewswire· 2026-01-05 11:15
Group 1 - Nexans has a liquidity contract with NATIXIS ODDO BHF, with assets reported as of December 31, 2025 [1] - The liquidity contract is in accordance with AMF decision no. 2018-01 and decision no. 2021-01 [1] - The company reported 27,951 shares and EUR 6,018,379.66 in cash as part of its liquidity account [4] Group 2 - Nexans generated €7.1 billion in standard sales in 2024 [2] - The company employs approximately 28,500 people across 41 countries [2] - Nexans is committed to achieving Net-Zero emissions by 2050, aligning with the Science Based Targets initiative (SBTi) [2]
Lectra: Half-year statement on the liquidity contract First half of 2025
Globenewswire· 2025-10-08 16:00
Core Points - The liquidity contract between LECTRA and NATIXIS-ODDO BHF has been active since October 1, 2022, and the half-year statement for the first half of 2025 has been released [2][4] - The trading volume of LECTRA shares from January 1, 2025, to June 30, 2025, is reported, showing significant trading activity [2][4] Summary by Category Trading Activity - From January 1, 2025, to June 30, 2025, a total of 174,119 LECTRA shares were purchased for €4,478,906 across 3,767 transactions, while 177,410 shares were sold for €4,595,582 across 3,877 transactions [4] - In the previous half-year period, from July 1, 2024, to December 31, 2024, 76,279 shares were purchased for €2,080,637 in 1,856 transactions, and 76,212 shares were sold for €2,092,534 in 1,692 transactions [4] Liquidity Account Status - As of June 30, 2025, the liquidity account held 34,096 LECTRA shares valued at €313,942 [4] - The liquidity account also had 35,468 LECTRA shares valued at €335,164 at the end of the previous half-year [4]
Rexel: biannual sharebuyback program at 30 June, 2025
Globenewswire· 2025-07-17 16:15
Group 1 - The liquidity agreement between Rexel and Natixis-Oddo BHF includes a liquidity account with 163,986 Rexel shares and €16,816,936 as of June 30, 2025, compared to 626,370 shares and €8,211,229 at the agreement's inception [1] - From January 1 to June 30, 2025, there were 7,163 purchase transactions totaling 3,616,873 Rexel shares and €90,484,529, while 7,795 sale transactions accounted for 3,778,193 shares and €95,593,527 [3][4] Group 2 - Rexel operates in the multichannel professional distribution of products and services for the energy sector, focusing on residential, non-residential, and industrial markets [7] - The company has a network of over 1,950 branches across 17 countries and employs more than 27,000 people, with sales reaching €19.3 billion in 2024 [7] - Rexel is listed on the Euronext Paris and included in various indices such as MSCI World and CAC 40 ESG, reflecting its commitment to corporate social responsibility [8]
Ipsen - Half year statement - 2025 06 30
Globenewswire· 2025-07-07 16:00
Core Insights - Ipsen has announced its half-year statement regarding the liquidity agreement with NATIXIS ODDO BHF, detailing the resources allocated to the dedicated liquidity account as of June 30, 2025 [1] - The company operates as a global biopharmaceutical entity focusing on transformative medicines in oncology, rare diseases, and neuroscience, leveraging nearly 100 years of development experience [2] - Ipsen is publicly listed on Euronext in Paris and has a Sponsored Level I American Depositary Receipt program in the U.S. [3] Financial Summary - As of June 30, 2025, the liquidity account included 38,030 shares valued at €1,320,416.64 and 12,751 shares valued at €3,137,934.80 [6] - The trading volume during the period from January 1, 2025, to June 30, 2025, included 2,468 purchase transactions and 2,393 sell transactions, with a total of 339,729 shares purchased for €36,644,907.65 and 326,400 shares sold for €35,329,344.25 [6]
Half-year statement on Nexans liquidity contract - January 1st to June 30th, 2025
Globenewswire· 2025-07-02 14:15
Group 1 - Nexans has a liquidity contract with NATIXIS ODDO BHF, with assets reported as of June 30, 2025 [1] - The liquidity contract is in accordance with AMF decision no. 2018-01 and decision no. 2021-01 [1] - Nexans generated €7.1 billion in standard sales in 2024 and is a leader in cable systems and services [2] Group 2 - Nexans employs approximately 28,500 people across 41 countries [2] - The company is committed to achieving Net-Zero emissions by 2050, aligned with the Science Based Targets initiative [2] - The liquidity account showed various transactions, including 49,612 shares and €3,006,649.02 in cash for the first half of 2025 [4]